H.R. 4586 — what changed

added “E Opioid Use Disorder

added “341. Opioid overdose reversal medication access and education grant programs

added “(a) Grants to States—The Secretary may make grants to States for—

added “(1) developing standing orders for pharmacies regarding opioid overdose reversal medication;

added “(2) encouraging pharmacies to dispense opioid overdose reversal medication pursuant to a standing order;

added “(3) implementing best practices for persons authorized to prescribe medication regarding—

added “(A) prescribing opioids for the treatment of chronic pain;

added “(B) co-prescribing opioid overdose reversal medication with opioids; and

added “(C) discussing the purpose and administration of opioid overdose reversal medication with patients;

added “(4) developing or adapting training materials and methods for persons authorized to prescribe or dispense medication to use in educating the public regarding—

added “(A) when and how to administer opioid overdose reversal medication; and

added “(B) steps to be taken after administering opioid overdose reversal medication; and

added “(5) educating the public regarding—

added “(A) the public health benefits of opioid overdose reversal medication; and

added “(B) the availability of opioid overdose reversal medication without a person-specific prescription.

added “(b) Certain requirement—A grant may be made under this section only if the State involved has authorized standing orders regarding opioid overdose reversal medication.

added “(c) Preference in making grants—In making grants under this section, the Secretary shall give preference to States that—

added “(1) have not issued standing orders regarding opioid overdose reversal medication;

added “(2) authorize standing orders that permit community-based organizations, substance abuse programs, or other nonprofit entities to acquire, dispense, or administer opioid overdose reversal medication;

added “(3) authorize standing orders that permit police, fire, or emergency medical services agencies to acquire and administer opioid overdose reversal medication;

added “(4) have a higher per capita rate of opioid overdoses than other applicant States; or

added “(5) meet any other criteria deemed appropriate by the Secretary.

added “(d) Grant terms

added “(1) Number—A State may not receive more than 1 grant under this section.

added “(2) Period—A grant under this section shall be for a period of 3 years.

added “(3) Amount—A grant under this section may not exceed $500,000.

added “(4) Limitation—A State may use not more than 20 percent of a grant under this section for educating the public pursuant to subsection (a)(5).

added “(e) Applications—To be eligible to receive a grant under this section, a State shall submit an application to the Secretary in such form and manner and containing such information as the Secretary may require, including detailed proposed expenditures of grant funds.

added “(f) Reporting—Not later than 3 months after the Secretary disburses the first grant payment to any State under this section and every 6 months thereafter for 3 years, such State shall submit a report to the Secretary that includes the following:

added “(1) The name and ZIP Code of each pharmacy in the State that dispenses opioid overdose reversal medication under a standing order.

added “(2) The total number of opioid overdose reversal medication doses dispensed by each such pharmacy, specifying how many were dispensed with or without a person-specific prescription.

added “(3) The number of pharmacists in the State who have participated in training pursuant to subsection (a)(4).

added “(g) Definitions—In this section:

added “(1) Opioid overdose reversal medication—The term “opioid overdose reversal medication” means any drug, including naloxone, that—

added “(A) blocks opioids from attaching to, but does not itself activate, opioid receptors; or

added “(B) inhibits the effects of opioids on opioid receptors.

added “(2) Standing order—The term “standing order” means a document prepared by a person authorized to prescribe medication that permits another person to acquire, dispense, or administer medication without a person-specific prescription.

added “(h) Authorization of appropriations

added “(1) In general—To carry out this section, there is authorized to be appropriated $5,000,000 for the period of fiscal years 2017 through 2019.

added “(2) Administrative costs—Not more than 3 percent of the amounts made available to carry out this section may be used by the Secretary for administrative expenses of carrying out this section.”

removed Part B of title III of the Public Health Service Act is amended by inserting after section 317T of such Act (42 U.S.C. 247b–22) the following:

removed “317U. Opioid Overdose Reversal Medication Access and Education Grant Programs

removed “(a) Grants to States—The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may make grants to States for—

removed “(1) developing standing orders for pharmacies regarding opioid overdose reversal medication;

removed “(2) encouraging pharmacies to dispense opioid overdose reversal medication pursuant to a standing order;

removed “(3) implementing guidelines and best practices for persons authorized to prescribe medication regarding—

removed “(A) prescribing opioids for the treatment of chronic pain;

removed “(B) co-prescribing opioid overdose reversal medication with opioids; and

removed “(C) discussing the purpose and administration of opioid overdose reversal medication with patients;

removed “(4) developing or adapting training materials and methods for persons authorized to prescribe or dispense medication to use in educating the public regarding—

removed “(A) when and how to administer opioid overdose reversal medication; and

removed “(B) steps to be taken after administering opioid overdose reversal medication; and

removed “(5) educating the public regarding—

removed “(A) the public health benefits of opioid overdose reversal medication; and

removed “(B) the availability of opioid overdose reversal medication without a person-specific prescription.

removed “(b) Certain requirement—A grant may be made under this section only if the State involved has authorized standing orders regarding opioid overdose reversal medication.

removed “(c) Preference in making grants—In making grants under this section, the Secretary shall give preference to States that—

removed “(1) have not issued standing orders regarding opioid overdose reversal medication;

removed “(2) authorize standing orders that permit community-based organizations, substance abuse programs, or other nonprofit entities to acquire, dispense, or administer opioid overdose reversal medication;

removed “(3) authorize standing orders that permit police, fire, or emergency medical services agencies to acquire and administer opioid overdose reversal medication;

removed “(4) have a higher per capita rate of opioid overdoses than other applicant States; or

removed “(5) meet any other criteria deemed appropriate by the Secretary.

removed “(d) Grant terms

removed “(1) Number—A State may not receive more than 1 grant under this section.

removed “(2) Period—A grant under this section shall be for a period of 3 years.

removed “(3) Amount—A grant under this section may not exceed $500,000.

removed “(4) Limitation—A State may use not more than 20 percent of a grant under this section for educating the public pursuant to subsection (a)(5).

removed “(e) Applications—To be eligible to receive a grant under this section, a State shall submit an application to the Secretary in such form and manner and containing such information as the Secretary may require, including detailed proposed expenditures of grant funds.

removed “(f) Reporting—Not later than 3 months after the Secretary disburses the first grant payment to any State under this section and every 6 months thereafter for 3 years, such State shall submit a report to the Secretary that includes the following:

removed “(1) The name and ZIP Code of each pharmacy in the State that dispenses opioid overdose reversal medication under a standing order.

removed “(2) The total number of opioid overdose reversal medication doses dispensed by each such pharmacy, specifying how many were dispensed with or without a person-specific prescription.

removed “(3) The number of pharmacists in the State who have participated in training pursuant to subsection (a)(4).

removed “(g) Definitions—In this section:

removed “(1) Opioid overdose reversal medication—The term “opioid overdose reversal medication” means any drug, including naloxone, that—

removed “(A) blocks opioids from attaching to, but does not itself activate, opioid receptors; or

removed “(B) inhibits the effects of opioids on opioid receptors.

removed “(2) Standing order—The term “standing order” means a document prepared by a person authorized to prescribe medication that permits another person to acquire, dispense, or administer medication without a person-specific prescription.

removed “(h) Authorization of appropriations

removed “(1) In general—To carry out this section, there is authorized to be appropriated $10,815,000 for the period of fiscal years 2016 through 2019.

removed “(2) Administrative costs—Not more than 3 percent of the amounts made available to carry out this section may be used by the Secretary for administrative expenses of carrying out this section.”